Schiffmann, Raphael <br/><br/>
The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.  [electronic resource] 

 -  Journal of inherited metabolic disease  Jan 2015 
 - 77-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1573-2665 
<br/><br/><label>Standard No.: </label>10.1007/s10545-014-9758-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Asthma--genetics<br/>Atherosclerosis--genetics<br/>Diabetes Mellitus--genetics<br/>Disease Models, Animal<br/>Glucose--chemistry<br/>Glucosyltransferases--genetics<br/>Humans<br/>Lipid Metabolism--genetics<br/>Lysosomes--metabolism<br/>Mice<br/>Polycystic Kidney Diseases--genetics<br/>Serine C-Palmitoyltransferase--genetics<br/>Sphingolipidoses--genetics<br/>Sphingolipids--biosynthesis<br/>Uridine Diphosphate--chemistry